Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, ...

Eli Lilly has won approval from Chinese regulators to sell its weight-loss treatment tirzepatide in the country, the company ...

Shares of Eli Lilly (LLY) are soaring after the pharmaceutical giant received regulatory approval in China for its GLP-1 ...

Eli Lilly & Co.’s Mounjaro gained Chinese regulatory approval for weight less than a month after a similar therapy from Novo ...

Eli Lilly (LLY) stock rises as Chinese drug regulator approves its weight loss therapy, tirzepatide, for long-term weight ...

Gov. Eric Holcomb will be taking another international economic development trip this summer — this time to Australia and ...

Eli Lilly (NYSE: LLY) announced on social media Friday that its weight loss drug, tirzepatide, has received approval from ...

Morphic only had eyes for Eli Lilly. While some takeover tales have casts of Shakespearean breadth, Lilly’s $3.2 billion ...

Eli Lilly announces that its weight loss drug, tirzepatide, has been approved by Chinese regulators. This move intensifies ...

U.S. pharmaceutical company Eli Lilly & Co.’s (LLY) weight loss medication called “Mounjaro” has been approved for use in ...

Mounjaro is designed for individuals with a body mass index greater than 24 kg/m² and at least one related medical condition, ...

Eli Lilly’s shares dropped 10% over just two days, and Novo Nordisk’s are down about 8% — cutting tens of billions of dollars ...